0001209191-23-023944.txt : 20230410
0001209191-23-023944.hdr.sgml : 20230410
20230410200749
ACCESSION NUMBER: 0001209191-23-023944
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230410
DATE AS OF CHANGE: 20230410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robbins Wendye
CENTRAL INDEX KEY: 0001791244
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 23812158
MAIL ADDRESS:
STREET 1: C/O RAPT THERAPEUTICS, INC.
STREET 2: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-31
0
0001673772
RAPT Therapeutics, Inc.
RAPT
0001791244
Robbins Wendye
C/O RAPT THERAPEUTICS, INC.
561 ECCLES AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Stock Option (right to buy)
18.35
2023-03-31
4
A
0
3616
14.52
A
2033-03-30
Common Stock
3616
3616
D
The shares subject to the option vest in four equal quarterly installments on the last day of each fiscal quarter in 2023 with the first installment vesting on March 31, 2023, provided that the reporting person is in service as a director on each such vesting date.
This option was issued to the reporting person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of an annual cash retainers for service on the Board of Directors and committees thereof in the aggregate amount of $52,500.
/s/ Rodney Young, Attorney-in-Fact for Wendye Robbins
2023-04-10